Localization of T25 glycoprotein in wild-type and Thy 1- mutant cells by immunofluorescence and immunoelectron microscopy by unknown
LOCALIZATION  OF  T25  GLYCOPROTEIN  IN  WILD-TYPE 
AND  THY  1-  MUTANT  CELLS 
BY  IMMUNOFLUORESCENCE  AND  IMMUNOELECTRON 
MICROSCOPY* 
BY LILLY  Y.  W.  BOURGUIGNON,$  ROBERT  HYMAN,§  IAN TROWBRIDGE,II 
AND S.  J.  SINGER¶ 
(From the Department of Biology, University of California, La Jolla, California 92093, and 
Cancer Biology Laboratory, Salk Institute, Box 1809, San Diego, California 92112) 
The  steps  in  the  biosynthesis  of cell  membrane  glycoproteins  and  their 
transport to the cell surface are not well understood. We have been studying a 
series of mutant cell lines which have blocks in their cell surface expression of 
T25, a membrane glycoprotein bearing the Thy 1 alloantigen (1, 2). Biochemical 
characterization of the nature of the blocks should provide information about 
specific steps in cell membrane glycoprotein biosynthesis. 
Five classes of Thy 1- mutants have been identified by complementation analysis (2, 
3). In somatic cell hybridization studies, mutants of each class complement mutants of 
all other classes but do not complement other mutants of the same class.  The genetic 
studies are consistent with the hypothesis that one mutant class  (class D) defines the 
structural  gene coding  for the Thy 1 alloantigenic determinant. The four remaining 
classes  (A, B, C, and E) define genes other than that coding for the Thy 1 determinant 
but whose action is necessary for expression of Thy 1 on the cell surface. 
The Thy 1 alloantigenic determinant is borne on a glycoprotein of approximate mol wt 
25-30,000 (4) which, in the mouse, has been termed T25 (5, 6). Mutants of classes A, B, 
C, and E synthesize T25 molecules which are structurally different from the wild-type 
glycoprotein and which are not expressed on the cell  surface, as determined by both 
biochemical  and serological  criteria (2,  7). 1 Pulse-chase  experiments showed  that the 
mutant  molecules are  degraded  faster than  the  wild-type molecules; ~ however,  the 
increased rate of  degradation of  the mutant molecules does not seem sufficient to account 
for the 500-1,000-fold deficit of T25 on the cell surface. 
The existence of separate mutant classes, each of  which synthesizes a mutant 
T25 molecule which does not reach the cell surface, raises questions about the 
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localization of T25 in mutant vs. wild-type cells and among the different mutant 
classes themselves. The T25 glycoprotein has been isolated from cultured mouse 
lymphoma  cells  and  has  been  used  to  prepare  a  rabbit  antiserum  which 
specifically reacts with T25. This antiserum has allowed us to use immunohis- 
tochemical methods to detect T25 in wild-type and mutant cells. In the present 
study we have  used  immunofluorescence  and  immunoelectron  microscopy to 
verify  the  absence  of T25  from  the  cell  membrane  of mutant  cells  and,  in 
preliminary experiments, to demonstrate directly the presence ofT25 molecules 
within mutant cells. 
Materials and Methods 
Cell Lines.  The wild-type AKR/J lymphoma line BW5147  (Thy  1  ÷) and the class A  mutant 
BW5147  (Thy l-a) have been described previously (3, 7).  (This mutant cell line was referred to as 
BW5147  (Thy  1-)  in  previous  publications).  The  cells  were  grown  in  suspension  culture  in 
Dulbecco's modified Eagle's medium with 10% horse serum (8). 
Rabbit  Anti-T25.  Rabbit  antiserum  against  T25  glycoprotein  was  prepared  by  repeated 
subcutaneous  injections of the purified glycoprotein in complete Freund's adjuvant.  A  detailed 
account  of the purification  of the  antigen  and  the properties  of the  antiserum  will be given 
elsewhere. Briefly, T25 glycoprotein was purified from BW5147  (Thy 1  +) cells by solubilization of 
a  crude  membrane  pellet with  sodium  deoxycholate,  ~actionation  on  a  pea  lectin-Sepharose 
column followed by gel filtration  (9).  The antiserum  against T25 glycoprotein was cytotoxic for 
Thy 1  + lymphomas but not Thy 1- mutant cells. One major radioactive species with a 25,000 mol 
wt and corresponding to T25,  was specifically precipitated by the antiserum from BW5147  (Thy 
1  +) cells labeled either by the lactoperoxidase surface-labeling technique or metabolically labeled 
with [SH]mannose or [~H]leucine. 
To demonstrate that intracellular staining was specific for T25, the rabbit anti-T25 antiserum 
was absorbed with intact BW5147  (Thy 1  +) cells to remove the anti-T25 antibodies, the remaining 
serum being used as a control. A pellet of 2 ×  108 viable cells was incubated with 0.25 ml of a 1:10 
dilution of the antiserum in phosphate-buffered saline for 30 min at room temperature.  The cells 
were then centrifuged into a  pellet and the supernate removed. This process was repeated three 
times. 
Immunolabeling  Reagents,  For  immunofluorescence  staining,  an  indirect  procedure  was 
used,  employing  affinity  purified  goat  antibodies  to  rabbit  IgG.  The  goat  antibodies  were 
conjugated with fluorescein isothiocyanate or with lissamine rhodamine B sulfonyl chloride (10). 
For  indirect  immunoferritin  staining,  the  goat  antibodies  were  conjugated  with  six  times 
recrystallized ferritin by the procedure of Kishida et al.  (11). 
Surface Immunofluorescent Labeling  of T25 Protein.  Both  the  wild-type and  mutant  cells 
were first treated in suspension with rabbit antisera to T25 protein in phosphate-buffered saline 
containing 0.2% bovine serum albumin,  pH 7.4 for 30 min at 0°C. After washing, the cells were 
then reacted with fluorescein-conjugated goat antibodies to rabbit IgG for 30 min at 0°C. After 
washing the cells free of unbound protein, they were then fixed with 2% formaldehyde in 0.1 M 
phosphate buffer, pH 7.4,  for 30 min at 0°C, and examined by fluorescent and Nomarski optics. 
Intracellular Immunofluorescent Labeling of T25 Protein.  Wild-type and  mutant  cells were 
fixed with 0.2% glutaraldehyde in 0.1  M phosphate buffer, pH 7.4 for 45 min at 0°C. Fixed cells 
were then kept overnight in 0.1 M phosphate buffer at 4°C, after which they were infused in 1.2 M 
sucrose, frozen, and sectioned in the frozen state. For immunofluorescent staining, such sectioning 
was carried out at about -30°C to section thicknesses of about 0.2 ~m, whereas for immunoferritin 
staining, sections were cut at -80°C to thicknesses of approximately 700/k (12-14).  Both types of 
sections, after thawing, were then stained with rabbit antisera to T25.  As controls, some sections 
were treated with normal rabbit IgG.  The thicker sections were then treated with rhodamine- 
conjugated goat antibodies to rabbit IgG and processed for fluorescence observations. (Rhodamine 
conjugates were used here rather than fluorescein conjugates because of the autofluorescene of 
the glutaraldehyde-treated cells.) The thinner sections, on electron microscope grids, were labeled 
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Microscopy.  Fluorescence observations were made with Zeiss Photoscope III by using a  ×63 
oil immersion lens and an epi-illuminator. Fluorescein and rhodamine fluorescences were excited 
with  an  Osram  HBO  50  W  bulb,  and  the  filter  combinations  CZ  487710  and  CZ  487714, 
respectively, were used for observations. Photography was performed with Kodak Plus X film. 
Electron microscopic observations were made with a Phillips Model 300 electron microscope at 
60 kV. 
Results and Discussion 
In this study we have used immunofluorescent and immunoelectron micro- 
scopic methods to directly visualize T25 in wild-type and Thy 1- mutant cells. 
The results confirm the interpretation based on serological and biochemical 
methods. The wild-type cell line BW5147  (Thy 1  ÷) when stained in the living 
state by indirect immunofluorescence, by using rabbit anti-T25 as the primary 
reagent, shows T25 clustered over the cell surface (Figs. la and b).  No surface 
fluorescence is seen when the class A  mutant cell line BW5147  (Thy l-a)  is 
stained in a  similar manner (Figs. 2a and b). In frozen sections examined by 
immunofluorescence, the wild-type cell line shows staining predominantly at 
the cell membrane with areas of weak diffuse cytoplasmic fluorescence (Fig. 3). 
In  contrast,  the  mutant  cell  line  shows  only  diffuse  patchy  fluorescence 
throughout the cytoplasm (Fig. 4). This cytoplasmic staining was absent when 
the anti-T25 antiserum was first absorbed with intact Thy 1" cells (data not 
shown). Therefore there was no evidence that the anti-T25 serum contained 
antibodies which recognized contaminating intracellular specificities. Controls 
using normal rabbit  serum  in  place  of the  antibodies  to  T25  were  always 
negative. 
A similar distribution of T25 was seen by immunofluorescence in mutants of 
classes C and E and their corresponding wild-type lines (data not shown). 
The development of ultrathin frozen sectioning methods of specimen prepa- 
ration for immunoferritin electron microscopy (12, 13) has allowed us to carry 
out preliminary experiments at the ultrastructural level to study the distribu- 
tion of T25 within the cytoplasm as well as on the surfaces of these cells. With 
the wild-type cells, the immunoferritin staining for T25 is mostly on the surface, 
with only light staining in the cytoplasm (Fig. 5). In the mutant cell line, little 
T25 is seen near the cell surface, but substantial amounts are found throughout 
the cytoplasm (Fig. 6). These results are therefore entirely consistent with the 
immunofluorescent results described.  Beyond that,  however, it is of interest 
that the immunoferritin staining is often observed in clusters (Fig. 6, arrows) 
extending up to the cytoplasmic face of the surface membrane. This suggests a 
partially vesicular distribution of T25 protein inside the mutant cells, possibly 
extending beyond the endoplasmic reticulum up to the plasma membrane. 
FIG.  1.  a) Indirect fiuorescein immunofluorescence staining of the T25 glycoprotein on the 
surfaces of intact BW5147 (Thy 1  +) cells, and b) the same field viewed with Nomarski optics. 
FIG.  2.  a)  The  absence of surface  staining for the T25  glycoprotein  on intact  BW5147 
(Thy l-a) cells, and b) the same field viewed with Nomarski optics. 
FIG.  3.  Fixed  frozen  sections of BW5147  (Thy  1  +) cells  stained by  indirect rhedamine 
immunofluorescence for the T25 glycoprotein. Note the largely surface staining of the cells. 
FIG.  4.  Fixed frozen sections of BW5147  (Thy  l-a) cells stained by indirect rhodamine 
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The genetic behavior of the class A, B,  C, and E mutants and the fact that 
each mutant of these classes synthesizes an incomplete T25 molecule suggested 
the  hypothesis  that  the  mutants  had  defects  in  posttranslational  steps  of 
biosynthesis. Since T25 is a glycoprotein, the most likely block seemed to be a 
defect in carbohydrate biosynthesis (2, 7). Evidence supporting this idea comes 
from two experimental approaches. First, biochemical studies on the radiola- 
beled glycopeptides of mutant and wild-type T25 glycoproteins show that the 
oligosaccharides of the  mutant molecules differ from those of the wild-type 
molecules.  1 Second, mutants with a Thy 1- phenotype and which complement 
with class E mutants have been selected by prolonged exposure of mutagenized 
wild-type cells to cytotoxic concentrations of concanavalin A  (I.  Trowbridge, 
and R. Hyman, unpublished results). The class E mutants show a pleiotropic 
defect which affects the glycosylation of many glycoproteins, although only T25 
is absent from the cell surface.1 
Hickman et al. (15) have shown that IgA and IgE-secreting murine myeloma 
cells  treated  with  tunicamycin, an  inhibitor  of glycosylation, show  greatly 
reduced secretion of myeloma protein. By immunofluorescence unglycosylated 
protein is found inside the cells where it is present in a punctate distribution. 
Vesicles formed by the endoplasmic reticulum are seen in the tunicamycin- 
treated cells,  and it was suggested that the unglycosylated myeloma protein is 
present mainly in these vesicles, but no immunoelectron microscopic observa- 
tions were made. 
To gain further information from immunoelectron microscopy on the specific 
nature of the blocks in different classes of Thy 1- mutant it will be necessary to 
use newly developed methods for positive staining of  frozen sections  2  to delineate 
better the internal membranes and ultrastructure of the cell. Furthermore, the 
use of synchronized cell cultures may permit the intracellular pathway of T25 
biosynthesis to be elucidated. 
Summary 
The wild-type BW5147 (Thy 1  +) cell line and its Thy 1- mutant derivative 
BW5147 (Thy l-a) were examined by immunofluorescence  and immunoelectron 
microscopy for the  presence of T25, the glycoprotein which bears the Thy 1 
alloantigen.  The wild-type cell had T25  predominantly localized on the cell 
surface.  In  the  mutant  cell  line,  T25  accumulated intracellularly and  was 
present  in  a  clustered distribution  throughout the  cytoplasm.  T25  was  not 
present on the surface of the mutant cell line in significant amount. 
Received for publication  19 January 1978. 
F~a.  5.  Immunoferritin staining for the T25 glycoprotein on fixed,  ultrathin frozen sec- 
tions of BW5147 (Thy 1 +) cells. Note the largely surface localization of the ferritin stain. 
Fro.  6.  Immunoferritin staining for the T25 glycoprotein on fixed,  ultrathin frozen sec- 
tions of BW5147 (Thy l-a) cells.  The ferritin stain is largely cytoplasmic and often seen 
in small clusters, up to the plasma membrane. 
2 K. Tokuyasu.  Manuscript submitted for publication. 1354  LOCALIZATION OF  T25  IN  THY  1-  CELLS 
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